Evaluation of Cis-diamminedichloroplatinum(II) Combined with Metoclopramide or Sodium Thiosulfate on L1210 Leukemia in Vitro and in Vivo
Overview
Authors
Affiliations
A microtiter assay was developed to monitor cytotoxic activity of drugs alone and in combination at varying ratios on a single plate. Combinations of metoclopramide or sodium thiosulfate with cis-diamminedichloroplatinum(II) (cisplatin) were evaluated in vitro and in vivo for cisplatin cytotoxicity to murine leukemia L1210. The in vitro assay indicated that metoclopramide did not interfere with cisplatin-induced cytotoxicity and confirmed previously reported inhibition of cisplatin activity by sodium thiosulfate. The drug combinations were also evaluated in vivo for antitumor activity and the results of these studies corroborated the in vitro results.
Treskes M, van der Vijgh W Cancer Chemother Pharmacol. 1993; 33(2):93-106.
PMID: 8261581 DOI: 10.1007/BF00685326.
Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
Schurig J, BRADNER W, Basler G, Rose W Invest New Drugs. 1989; 7(2-3):173-8.
PMID: 2793369 DOI: 10.1007/BF00170854.
DeGregorio M, Gandara D, Holleran W, Perez E, King C, Wold H Cancer Chemother Pharmacol. 1989; 23(5):276-8.
PMID: 2539912 DOI: 10.1007/BF00292403.
Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
Schurig J, Rose W, Kamei H, Nishiyama Y, BRADNER W, Stringfellow D Invest New Drugs. 1990; 8(1):7-15.
PMID: 2345072 DOI: 10.1007/BF00216919.
The effect of age on the pharmacokinetics of ifosfamide.
Lind M, Margison J, Cerny T, Thatcher N, Wilkinson P Br J Clin Pharmacol. 1990; 30(1):140-3.
PMID: 2167716 PMC: 1368286. DOI: 10.1111/j.1365-2125.1990.tb03754.x.